title: Aspergillus fumigatus osteomyelitis in a patient receiving alemtuzumab for B-cell chronic lymphocytic leukaemia.
authors.affiliation: Departments of Haematology Radiology, University Hospitals Leicester, Leicester Royal Infirmary, Leicester, UK. sumitkaria@yahoo.co.uk
authors.forename: Sumit
authors.initials: S
authors.lastname: Karia
authors.forename: Kanagaratnam
authors.initials: K
authors.lastname: Jeyapalan
authors.forename: Ben
authors.initials: B
authors.lastname: Kennedy
mesh_terms: D000368:Aged; D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001228:Aspergillosis / Q000139:chemically induced / Q000473:pathology; D001232:Aspergillus fumigatus; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000473:pathology; D010019:Osteomyelitis / Q000139:chemically induced / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000074323:Alemtuzumab